These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8674659)

  • 21. Roles of key active-site residues in flavocytochrome P450 BM3.
    Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
    Haines DC; Sevrioukova IF; Peterson JA
    Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
    Roitel O; Scrutton NS; Munro AW
    Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
    Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
    Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
    Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.
    Munro AW; Malarkey K; McKnight J; Thomson AJ; Kelly SM; Price NC; Lindsay JG; Coggins JR; Miles JS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):423-8. PubMed ID: 7980400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavin supported fatty acid oxidation by the heme domain of Bacillus megaterium cytochrome P450BM-3.
    Gonvindaraj S; Li H; Poulos TL
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1745-9. PubMed ID: 7945324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
    Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
    Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADPH oxidase activity of cytochrome P-450 BM3 and its constituent reductase domain.
    Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
    Biochim Biophys Acta; 1995 Oct; 1231(3):255-64. PubMed ID: 7578214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
    Chen Z; Ost TW; Schelvis JP
    Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
    Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
    Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel inhibitor of cytochrome P450 BM3.
    Munro AW; Coggins JR; Lindsay JG
    Biochem Soc Trans; 1993 Nov; 21(4):411S. PubMed ID: 8131985
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of replacement of ferriprotoporphyrin IX in the haem domain of cytochrome P-450 BM-3 on substrate binding and catalytic activity.
    Modi S; Primrose WU; Lian LY; Roberts GC
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):939-43. PubMed ID: 7575430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
    Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
    Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residue size at position 87 of cytochrome P450 BM-3 determines its stereoselectivity in propylbenzene and 3-chlorostyrene oxidation.
    Li QS; Ogawa J; Schmid RD; Shimizu S
    FEBS Lett; 2001 Nov; 508(2):249-52. PubMed ID: 11718725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of electron transfer in neuronal NO synthase.
    Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
    Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new approach to the study of protein-protein interaction by FTIR: complex formation between cytochrome P450BM-3 heme domain and FMN reductase domain.
    Kariakin A; Davydov D; Peterson JA; Jung C
    Biochemistry; 2002 Nov; 41(46):13514-25. PubMed ID: 12427012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor/fatty acid interactions with cytochrome P-450 BM3.
    Macdonald ID; Smith WE; Munro AW
    FEBS Lett; 1996 Nov; 396(2-3):196-200. PubMed ID: 8914986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.